ArticleWorld journal of clinical cases2023

Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience.

Yao-Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.